vimarsana.com
Home
Live Updates
Actinium s Four Presentations at ASH Highlight the Positive
Actinium s Four Presentations at ASH Highlight the Positive
Actinium s Four Presentations at ASH Highlight the Positive Outcomes for Iomab-B and Actimab-A in Patients with Relapsed or Refractory Acute Myeloid Leukemia
NEW YORK - Actinium Pharmaceuticals, Inc. , a leader in the development of targeted radiotherapies, today highlighted four presentations at the 65th Annual American Society of Hematology Annual...
Related Keywords
United States ,
American ,
Sandesh Seth ,
Astellas Pharma ,
Actimaba National Cancer Institute ,
American Society Of Hematology Annual Meeting Exposition ,
Oncology Lg Chem Life Sciences ,
Actinium Pharmaceuticals Inc ,
Exchange Commission ,
Hematology Annual Meeting ,
Multiple High Risk ,
Complete Remission ,
Karnofsky Performance Status ,
National Cancer Institute ,
Life Sciences ,
News Publishing ,
Markets ,